Heung Dong Kim
연세대학교 의과대학 · 의학
김흥동 교수의 연구실은 주로 소아 간질 및 뇌신경질환의 비약물적 치료에 초점을 맞추고 있습니다. 특히 치료에 내성인 간질 환자에게 효과적인 ketogenetic 다이어트(KD)의 적용과 기전 연구, 그리고 뇌졸중 환자의 삼킴기능 장애 개선을 위한 혀 기능 향상 훈련(예: 혀- palate 저항 훈련)에 대한 임상 연구를 진행하고 있습니다. 또한, 레지제이브 수술을 통한 LGS(Lennox-Gastaut 증후군) 치료의 임상적 성과 분석을 통해 신경외과적 접근의 가치를 규명하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
The MAD might be considered as the primary choice for the treatment of intractable epilepsy in children, but the classic KD is more suitable as the first line of diet therapy in patients <2 years of age.
Tongue function can affect both the oral and pharyngeal stages of the swallowing process, and proper tongue strength is vital for safe oropharyngeal swallowing. This trial investigated the effect of tongue-to-palate resistance training (TPRT) on tongue strength and oropharyngeal swallowing function in stroke with dysphagia patients. This trial was performed using a 4-week, two-group, pre-post-design. Participants were allocated to the experimental group (n = 18) or the control group (n = 17). Th
Resective surgery is a viable option in some patients to treat seizures that are associated with LGS, with a high probability of seizure control and better adaptive function.
The ketogenic diet (KD) is a high-fat, low-carbohydrate diet, in which fat, instead of glucose, acts as a major energy source through the production of ketone bodies. The KD was formally introduced in 1921 to mimic the biochemical changes associated with fasting and gained recognition as a potent treatment for pediatric epilepsy in the mid-1990s. Recent clinical and scientific knowledge supports the use of the KD in drug-resistant epilepsy patients for its anti-seizure efficacy, safety, and tole
